Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arch Toxicol. 2019 Apr 23;93(6):1543–1553. doi: 10.1007/s00204-019-02446-1

Fig. 4.

Fig. 4

Light micrographs of a myocytes in hematoxylin–eosinstained sections and c interstitial and e perivascular fibrosis in Sirius red-stained sections of the LV wall in representative wild-type and Ahr−/− mice treated with Ang II and fenofibrate. Scale bars, 100 μm. Quantitative analysis of b myocyte cross-sectional area, c interstitial fibrosis, and f perivascular fibrosis and in the left ventricle of wild-type and Ahr−/− mice treated with Ang II and fenofibrate. Data are mean ± SEM of six mice per group. *P < 0.05 vs. wild-type control mice; #P < 0.05 vs. wild-type Ang II mice; P < 0.05 vs. Ahr−/− Ang II mice